Notice of Intent to Sole Source – R&D Systems
ID: 24-009764Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/0afea02a8a1d416eba1cd49dbc6c5acb/view
Timeline
    Description

    Notice of Intent to Sole Source – R&D Systems

    The Department of Health and Human Services, Department of, National Institutes of Health, intends to award a fixed price purchase order to Bio-Techne for Bio-techne kits used for molecular profiling of histological samples following high intensity focused ultrasound (HIFU) at the National Institutes of Health (NIH) Clinical Center (CC) Department of Radiology & Imaging Sciences (RADIS). These kits are used for biological product manufacturing and fall under the category of laboratory equipment and supplies. The procurement will take place in Bethesda, Maryland, United States. The proposed vendor, BioTechne, is the only source available to provide the kits with the required specifications needed by the NIH CC RADIS department. This acquisition is being conducted using simplified acquisition procedures and is not open for competition. Interested parties may submit their capabilities and interest in response to this notice. The closing date for submissions is August 1st, 2024 at 2pm EST. For more information, contact Kristin Nagashima, Contract Specialist at kristin.nagashima@nih.gov.

    Point(s) of Contact
    Kristin Nagashima
    kristin.nagashima@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Notice of Intent to Sole Source – R&D Systems
    Currently viewing
    Special Notice
    Similar Opportunities
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    Notice of Intent to Sole Source – BioRender
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to BioRender for the provision of licenses for their online scientific illustration software. This acquisition aims to supply the Clinical Center HEFS Department with full access to BioRender for a 12-month period, facilitating the estimation of costs through RS Means Construction and Renovation Packages. BioRender is recognized as the sole authorized developer and distributor of this software, which is essential for creating scientific illustrations efficiently. Interested parties may express their interest and capabilities to Kristin Nagashima at kristin.nagashima@nih.gov by September 11, 2024, at 4 PM EST, as this notice serves as an intent rather than a request for quotations.
    Installation of 18x Boom Arms for a Tandem Boom System (Notice of Intent to Sole Source)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to negotiate a sole source contract for the installation of 18 new 2nd Boom Arms for a Tandem Boom System at the NIH Clinical Center in Bethesda, Maryland. This procurement aims to replace existing respiratory boom systems in the ICU suite, which have been deemed inadequate by users, and to ensure the functionality of the new equipment through necessary deinstallation and reinstallation of medical gas, electrical, and telecommunication lines. The project is critical for enhancing medical equipment efficiency and safety, reflecting a responsive approach to user feedback. Interested parties may submit capability statements to Lu Chang at lu-chang.lu@nih.gov by 4:00 PM EST on September 9, 2024, as this is not a request for proposal but a notice of intent to sole source to KR Wolfe Inc. and its subcontractor, Hillrom (now Baxter International).
    Notice of Intent to Sole Source – Sharp Electronics Corp
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Sharp Electronics Corp for the procurement of multimedia devices aimed at enhancing patient engagement within the NIH Language Pathology Division. The acquisition includes specific items such as Sharp / NEC M431 displays, integrated PCs, and associated accessories, which are deemed essential for the division's operations. This procurement is conducted under the Federal Acquisition Regulation (FAR) Part 13, allowing for a sole source award due to the unique capabilities of Sharp Electronics to meet the NIH's requirements. Interested parties may express their interest and capabilities to Kristin Nagashima at kristin.nagashima@nih.gov by September 11, 2024, at 4 PM EST.
    Notice of Intent to Sole Source – Cardinal Health, Inc.
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a sole source contract to Cardinal Health, Inc. for the procurement of Floxuridine Vials, which are essential for patient care at the NIH Clinical Center in Bethesda, Maryland. The contract will involve a fixed price purchase order for 15 units of Floxuridine for Injection, catalog number 0143-9270-01, as Cardinal Health, Inc. is the only distributor of this medication in the United States. This acquisition is being conducted under the Federal Acquisition Regulation (FAR) Part 13, allowing for a sole source award due to the unique availability of the product. Interested parties may express their interest and capabilities by contacting Kristin Nagashima at kristin.nagashima@nih.gov by September 16, 2024, at 2 PM EST.
    Notice of Intent to Sole Source – Cox Subscriptions
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Cox Subscriptions, Inc. for the renewal of the Elsevier Clinical Skills Nursing Online Manual subscription, which is critical for the NIH Clinical Center (CC) nursing staff. This acquisition aims to provide essential resources that enhance patient care for individuals participating in clinical research, as the Elsevier Clinical Skills Nursing Online Manual has been a vital tool for the nursing staff over the years. The contract will be awarded under the Federal Acquisition Regulation (FAR) Part 13, allowing for a sole source procurement due to the unique nature of the required subscription, which is not available from any other vendor. Interested parties may express their interest and capabilities to Kristin Nagashima at kristin.nagashima@nih.gov by September 10, 2024, at 10 AM EST.
    Notice of Intent to Sole Source for the Bio-techne Ella cartridges kits and consumables.
    Active
    Dept Of Defense
    The Department of Defense, through the Army Medical Research Acquisition Activity, intends to award a sole-source contract to Bio-Techne Sales Corporation for the procurement of Bio-techne Ella cartridges kits and consumables. This acquisition aims to secure reagent kits compatible with the Biotechne Ella analyzer, which are essential for the U.S. Army Research Institute of Environmental Medicine's operations. The total estimated value of the contract is $4,200,000, and interested parties are invited to submit capability statements to Roberto Gonzalez by 10:00 A.M. EST on September 12, 2022, as no competitive proposals will be solicited.
    Notice of Intent: Gemini Bio-GemCell TM Plus Xeno free Reagents
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a sole-source contract to Gemini Bio for the supply of GemCell™ Plus Xeno-Free reagents, essential for the Center for Cellular Engineering's operations in Bethesda, Maryland. This procurement is critical as the Center relies on these specific reagents for manufacturing human cell and tissue-based products used in clinical trials, which are vital for patient care and treatment protocols. The unique compatibility of Gemini Bio's products with existing manufacturing processes makes them the only viable source, as switching vendors would incur significant costs and delays, potentially impacting patient outcomes. Interested parties may submit capability statements to Sheri Eiri at sheri.eiri@nih.gov by September 8, 2024, at 12:00 PM EST for consideration.
    Harris OnPoint’s AcuityPlus system Software upgrades and maintenance 6 month project (Notice of Intent to sole source)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to negotiate a sole-source contract with Quadramed Corporation (Harris OnPoint) for software upgrades and maintenance of the AcuityPlus system over a six-month period. The objective of this procurement is to enhance the existing AcuityPlus system, which is critical for assessing patient care needs and managing nursing resources effectively within the NIH Clinical Center. This software, utilized since 2008, plays a vital role in ensuring adequate nursing coverage and improving operational efficiency in patient care settings. Interested parties may submit capability statements by September 9, 2024, to Lu Chang at lu-chang.lu@nih.gov, as this is not a request for proposals and the contract period is set from September 16, 2024, to May 16, 2025.
    Acquisition of a U-Rhythm Device for Endocrine and Metabolic Investigation
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the acquisition of a U-Rhythm device intended for endocrine and metabolic research at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The procurement aims to obtain U-RHYTHM microdialysis collection devices, which are crucial for monitoring hormone levels in interstitial tissue fluid over extended periods in real-world settings, and includes essential components such as a portable syringe pump, microdialysis catheter, tubing assemblies, and processing kits. This equipment is vital for advancing scientific understanding and treatment options in endocrine and metabolic health. Interested vendors should contact Amber Harris at amber.harris@nih.gov for further details, as the solicitation is not set aside for small businesses and will be evaluated based on technical compliance and cost, with a Firm-Fixed Price purchase order to be delivered and accepted at the NIH facility in Bethesda, Maryland.